Five Parallel Post-Market Obligations for Medical Devices in Canada

1. Key takeaways

Canada’s post-market obligations for medical devices run along five parallel lines: the annual licence review (MDEL, before 1 April each year), adverse event reporting (sections 59 to 61, 10 days / 30 days), recall reporting (section 63.2 24 hours, sections 64 and 65 30 calendar days), documented procedures for distribution records, complaint handling and more (sections 52(3), 58, 58.1), and the annual refresh of supplier information (new sections 45(f.1)(f.2), from 2026-12-14).

• The five lines run on different types of clocks: calendar dates, clocks starting from awareness, clocks starting from decisions, continuous maintenance, and annual refresh.
• The annual licence review is a calendar point (before 1 April); event reporting runs from awareness (10 days / 30 days).
• Recalls combine a post-decision clock (24 hours) with a post-completion clock (30 calendar days).
• Documented procedures are a continuous duty; supplier information is an annual refresh from 2026-12-14.
• The right to sell fee of 460 CAD applies from 2026-04-01 under section 77 of the Order Establishing Fees Payable for Licences Related to Drugs and Medical Devices.
• Obtaining the MDL is not the end of the obligations but a change of track: from submission and review to reporting and maintenance.
• Under section 45(a)(b), changes must be notified within 15 calendar days, which is a separate timer from the ALR even though both concern licence maintenance.
• Because each line has its own clock and its own owner, the recommended model is one table with five rows, reviewed on a fixed cycle.

2. Legal basis

Each of the five lines rests on its own provision of the Medical Devices Regulations, and one line also carries a fee consequence under the fee order. The table below lists the provisions relied on in this article.

3. Expert insights

The five-line structure is the most useful mental model for Canadian post-market work, because each line has a different timing logic and a different failure mode. The insights below explain how the lines interact.

Insight 1: the five lines use different timing conventions.

The annual licence review is a calendar point (before 1 April); incident reporting runs from awareness (10 days / 30 days); recalls run from the decision (24 hours) and from completion (30 calendar days); documented procedures must be continuously maintained; and supplier information is an annual refresh. A single reminder mechanism must be configured differently for each line; one uniform alarm setting cannot serve all five. In practice this means the compliance calendar is not one calendar but a layered set: annual anchors, event-driven countdowns, and standing duties that never close.

Insight 2: obtaining the MDL is not the end of the obligations, but a change of track.

Before market entry the work is “submission and review”; after market entry it is “reporting and maintenance”. When a company obtains its MDL, the processes for all five lines should already be live, rather than being built after an incident occurs. Building them after the fact means the first event is handled by a process that has never been rehearsed.

Insight 3: the five lines converge at the import stage.

An MDEL that is not reviewed on time affects the licence status, which in turn fails the MDEL verification at the import stage. The execution quality of the post-market obligations therefore shows up directly in how smoothly goods move across the border. A lapse on any one line can translate into a customs-level delay, even though the lapse itself occurred months earlier.

Insight 4: the five lines together form the evidentiary surface for inspections.

According to the regulatory impact analysis statement of SOR/2026-110, inspections found that procedures are “often missing, have gaps and may be out of date”. This means the operating records of the five lines will become the key evidence sought in inspections, rather than mere confirmation that documents exist. Companies should treat every line as something that leaves a visible, dated trail of operation. A line that runs silently — with no tickets, no dated records and no named owner — is indistinguishable from a line that does not run at all, and this is precisely what the inspection findings cited above target.

4. Practical recommendations

• Manage the work with a single five-line table: for each line, list the governing provisions, the deadline, the responsible person, and the location of the operating records.
• Bring all five lines live before obtaining the MDL.
• Set calendar-point items (the ALR) as fixed annual work items; set timer items (incident reporting, recalls) as countdown processes.
• Bind continuous items (distribution records, complaint handling) to the daily business flow so that operating records form naturally.
• Fold the annual refresh item (supplier information) into the ALR cycle so it is executed together.

5. Verification checklist

• □ A five-line table has been established (provisions, deadlines, responsible persons, record locations)
• □ All five line processes were live before obtaining the MDL
• □ The ALR (before 1 April) has been set as a fixed annual work item
• □ Incident reporting (10 days / 30 days) and recalls (24 hours / 30 calendar days) have been set as countdown processes
• □ Distribution records and complaint handling have been bound to the daily business flow
• □ Supplier information has been folded into the ALR annual refresh

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com